4-Bromo-2-(2,2,2-trifluoroethyl)-2,3-dihydropyridazin-3-one, >95%, 1g

tert-Butyl (5R)-5-hydroxy-3,3-dimethylpiperidine-1-carboxylate, 98%, 250mg

2-Methyl-1H-pyrrolo[3,2-b]pyridine, 95.0%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)amino)propanoic acid, 97%, 1g

2-[(2,2,2-trifluoroethyl)amino]acetic acid hydrochloride, 98%, 250mg

Benzene D6, 99.5 at%D, 10 ml, glass packaging

ETHYL 1-BENZYL-4-METHYLPIPERAZINE-2-CARBOXYLATE, 95.0%, 250mg

3-Bromophenyl glyoxal hydrate, 250mg

(6-Bromoimidazo[1,2-a]pyridin-2-yl)acetic acid, 97.0%, 1g

tert-Butyl cyclobutanecarboxylate, 98%, 1g

N-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propionamide, 98%, 250mg

Alloc-Val-Ala-PAB-OH>97.0%(HPLC)(N)250mg

4,4,5,5-Tetramethyl-2-(2-methyl-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane, 97%, 5g